Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil

by Jasper Ubels, Craig Sable, Andrea Z. Beaton, Maria Carmo P. Nunes, Kaciane K. B. Oliveira, Lara C. Castro, Isabella M. Teixeira, Gabriela Z. L. Ruiz, Letícia Maria M. Rabelo, Alison R. Tompsett, Antonio Luiz P. Ribeiro, Klas-Göran Sahlen, Bruno R. Nascimento, On behalf of the PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e Outras Doenças Cardiovasculares) investigators
Published 2020-02-01